+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Prognostic significance of pretreatment serum cytokines in classical Hodgkin lymphoma



Prognostic significance of pretreatment serum cytokines in classical Hodgkin lymphoma



Clinical Cancer Research 19(24): 6812-6819



Although the International Prognostic Score (IPS) is the gold standard for risk-stratifying patients with classical Hodgkin lymphoma (cHL), these criteria do not accurately predict outcome. As cytokines are critically involved in driving cHL, we tested whether pretreatment serum cytokine levels could provide additional prognostic information. Thirty cytokines were measured in pretreatment serum from 140 patients with cHL and compared with 50 nonlymphoma controls. Patients were followed for event-free survival (EFS) and overall survival (OS), and Cox proportional hazards regression models were used to assess the association of individual cytokines and the cytokine profiles with outcome via unadjusted and IPS-adjusted HR. Twelve cytokines (EGF, bFGF, G-CSF, HGF, IL-6, IL-8, IL-12, IL-2R, IP-10, MIG, TNF-α, and VEGF) were significantly (P < 0.05) higher in patients with cHL than controls; elevated levels of HGF, IL-6, IL-2R, IP-10, and MIG were all associated with poorer EFS. Only interleukin-2 receptor (IL-2R; P = 0.002) and interleukin (IL)-6 (P < 0.001) were independently prognostic. Patients with increased IL-6 and IL-2R had a significantly higher risk of early relapse and death, a finding that remained significant even after IPS-based risk stratification. Although elevated IL-6 and IL-2R correlated with the IPS, soluble CD30 (sCD30), and thymus and activation-related chemokine (TARC) levels, the two-cytokine model remained independently predictive of prognosis. Elevated pretreatment serum cytokines are associated with increased disease relapse and inferior survival in cHL. Thus, the pretreatment cytokine profile, particularly serum levels of IL-6 and IL-2R, may be used to identify patients with cHL at high risk for early-disease relapse.

(PDF emailed within 0-6 h: $19.90)

Accession: 055212898

Download citation: RISBibTeXText

PMID: 24141626

DOI: 10.1158/1078-0432.CCR-13-1879


Related references

Prognostic serum cytokines in classical Hodgkin lymphoma--letter. Clinical Cancer Research 20(24): 6633-6633, 2015

Prognostic value of pretreatment serum beta-2 microglobulin level in advanced classical Hodgkin lymphoma treated in the modern era. Oncotarget 7(44): 72219-72228, 2016

Prognostic significance of CD20 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin's Lymphoma. Ai Zheng 27(11): 1197-1203, 2008

Classical Hodgkin lymphoma, lymphocyte depleted type: clinicopathological analysis and prognostic comparison with other types of classical Hodgkin lymphoma. Pathology, Research and Practice 209(4): 201-207, 2013

Expression and prognostic significance of microenvironment related prognostic factors in patients with classical Hodgkin's lymphoma. Zhonghua Yi Xue Za Zhi 97(18): 1400-1405, 2018

Imbalances of chemokines, chemokine receptors and cytokines in Hodgkin lymphoma: classical Hodgkin lymphoma vs. Hodgkin-like ATLL. International Journal of Cancer 106(5): 706-712, 2003

Expressions and prognostic significance of PTEN and PD-1 protein in patients with classical Hodgkin's lymphoma. Zhonghua Xue Ye Xue Za Zhi 39(10): 839-844, 2018

Prognostic significance of new immunohistochemical markers in refractory classical Hodgkin lymphoma: a study of 59 cases. Plos One 4(7): E6341-E6341, 2009

Prognostic significance of CD20 expression in classical Hodgkin lymphoma: a clinicopathological study of 119 cases. Clinical Cancer Research 9(4): 1381-1386, 2003

Prognostic significance of T-cell or cytotoxic molecules phenotype in classical Hodgkin's lymphoma: a clinicopathologic study. Journal of Clinical Oncology 24(28): 4626-4633, 2006

The prognostic significance of CD20 expression in classical Hodgkin lymphoma A clinico-pathological study of 119 cases. Pathology Research & Practice 199(4): 206, 2003

Expression of heat shock proteins in classical Hodgkin lymphoma: correlation with apoptotic pathways and prognostic significance. Histopathology 58(7): 1072-1080, 2011

Prevalence and prognostic significance of Epstein-Barr virus infection in classical Hodgkin's lymphoma: a meta-analysis. Archives of Medical Research 45(5): 417-431, 2014

Prognostic significance of pretreatment ¹⁸F-FDG PET/CT in patients with relapsed/refractory B-cell non-Hodgkin's lymphoma treated by radioimmunotherapy using ¹³¹I-rituximab. Acta Haematologica 130(2): 74-82, 2013

Serum ferritin as prognostic marker in classical Hodgkin lymphoma treated with ABVD-based therapy. Leukemia & Lymphoma 56(11): 3096-3102, 2016